# FDA Inspection 1158637 - GlaxoSmithKline Research & Development Limited - May 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/9624d81a-fb84-4897-ad1d-ae8d8d05c105
Source feed: FDA_Inspections

> FDA Inspection 1158637 for GlaxoSmithKline Research & Development Limited on May 16, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1158637
- Company Name: GlaxoSmithKline Research & Development Limited
- Inspection Date: 2017-05-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 984370 - 2016-06-24](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/ced7207d-c78d-49ee-9fc7-34b9297a7995)
- [FDA Inspection 802584 - 2012-10-11](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/13eb5671-98f2-4743-8c02-2b46e362846a)
- [FDA Inspection 643994 - 2009-12-17](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-research-development-limited/96ec7247-ed53-458b-a3ec-3d73151a6d35)

Company: https://www.keypedia.com/companies/glaxosmithkline-research-development-limited/900caf13-e96b-46b5-8205-2a054736b8ef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c